GATA-3 is upregulated in peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome

Clinical Nephrology

Volumn 71, Issue 6, 2009, Pages 608-616

  Komatsuda, A ^a   Wakui, H ^a   Iwamoto, K ^a   Togashi, M ^a   Masai, R ^a   Maki, N ^a   Sawada, K ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

GATA 3; IL 13; IL 2; Minimal change nephrotic syndrome; Real time reverse transcription polymerase chain reaction; Stat5

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; STAT5A PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; STAT5 PROTEIN; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ADULT; AGED; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROSIS; NEPHROTIC SYNDROME; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; T LYMPHOCYTE ACTIVATION; TH2 CELL; UPREGULATION; ADOLESCENT; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; LIPOID NEPHROSIS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; RNA, MESSENGER; STAT5 TRANSCRIPTION FACTOR; T-BOX DOMAIN PROTEINS; UP-REGULATION; YOUNG ADULT;

EID: 67651012557     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71608     Document Type: Article

References (36)

1. Arakawa S, Hatano Y, Katagiri K. Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitis. Clin Exp Immunol. 2004; 135: 505-510.
2. Audard V, Larousserie F, Grimbert P et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006; 69: 2251-2260.
3. Cattran DC, Alexopoulos E, Heering P et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int. 2007; 72: 1429-1447.
4. Chan RW, Lai FM, Li EK et al. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology. 2006; 45: 951-957.
5. Cho B-S, Yoon S-R, Jang J-Y, Pyun K-H, Lee C-E. Up-regulation of interleukin-4 and CD23/FcεRII in minimal change nephrotic syndrome. Pediatr Nephrol. 1999; 13: 199-204.
6. Chu E, Rosenwasser LJ, Dinarello CA, Lareau M, Geha RS. Role of interleukin 1 in antigen-specific T cell proliferation. J Immunol. 1984; 132: 1311-1316.
7. Daniel V, Trautmann Y, Konrad M, Nayir A, Schärer K. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol. 1997; 47: 289-297.
8. Falk RJ, Jennette JC, Nachman PH. Primary glomerular disease. In: Brenner BM (eds). Brenner and Rector's The Kidney. Philadelphia: Saunders; 2004; p. 1293-1380.
9. Ho I-C, Pai S-Y. GATA-3 - not just for Th2 cells anymore. Cell Mol Immunol. 2007; 4: 15-29.
10. Hinoshita F, Noma T, Tomura S, Shiigai T, Yata J. Decreased production and responsiveness of interleukin 2 in lymphocytes of patients with nephrotic syndrome. Nephron. 1990; 54: 122-126.
11. Japanese Society of Nephrology. Clinical Practical Guidebook for Diagnosis and Treatment of Chronic Kidney Disease (in Japanese). Tokyo Igakusha; Japan: 2007. p. 33-35.
12. Kawasaki Y, Suzuki J, Sakai N et al. Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis. Am J Kidney Dis. 2004; 44: 42-49.
13. Kimura J, Takada H, Nomura A et al. Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease. Clin Exp Immunol. 2004; 137: 444-449.
14. Kishikawa H, Sun J, Choi A, Miaw S-C, Ho I-C. The cell type-specific expression of themurine IL-13 gene is regulated by GATA-3. J Immunol. 2001; 167: 4414-4420.
15. Komatsuda A, Wakui H, Iwamoto K et al. Gene expression profiling of peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome by cDNAmicroarrays. Am J Nephrol. 2008; 28: 539-547.
16. Kuroki A, Iyoda M, Shibata T, Sugisaki T. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int. 2005; 68: 302-310.
17. Lai K-W, Wei C-L, Tan L-K et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol. 2007; 18: 1476-1485.
18. Lama G, Luongo I, Tirino G et al. T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis. 2002; 39: 958-965.
19. Lavenu-Bombled C, Trainor CD, Makeh I, Romeo P-H, Max-Audit I. Interleukin-13 gene expression is regulated by GATA-3 in T cells: role of a critical association of a GATA and two GATG motifs. J Biol Chem. 2002; 277: 18313-18321.
20. Lit LC,Wong C-K, Li EK et al. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol. 2007; 34: 89-96.
21. Macaubas C, Lee PT, Smallacombe TB et al. Reciprocal patterns of allergen-induced GATA-3 expression in peripheral blood mononuclear cells from atopics vs. non-atopics. Clin Exp Allergy. 2002; 32: 97-106.
22. Mathieson PW. Immune dysregulation in minimal-change nephropathy. Nephrol Dial Transplant. 2003; 18 (Suppl 6): vi26-vi29.
23. Matsuoka K, Inoue N, Sato T et al. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohns disease. Gut. 2004; 53: 1303-1308.
24. Neuhaus TJ, Wadhwa M, Callard R, Barratt TM. Increased IL-2, IL-4 and interferon-γ (IFN-γ) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol. 1995; 100: 475-479.
25. Neurath MF, Weigmann B, Finotto S et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med. 2002; 195: 1129-1143.
26. Ranganath S, Ouyang W, Bhattarcharya D et al. GATA-3-dependent enhancer activity in IL-4 gene regulation. J Immunol. 1998; 161: 3822-3826.
27. Shaw J, Meerovitch K, Bleackley RC, Paetkau V. Mechanisms regulating the level of IL-2mRNAin Tlymphocytes. J Immunol. 1988; 140: 2243-2248.
28. Shimoyama H, Nakajima M, Naka H et al. Up-regulation of interleukin-2 mRNA in children with idiopathic nephrotic syndrome. Pediatr Nephrol. 2004; 19: 1115-1121.
29. Stachowski J, Barth C, Michalkiewicz J et al. Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome. Pediatr Nephrol. 2000; 14: 779-785.
30. Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-α in the nephrotic syndrome in humans. Am J Kidney Dis. 1993; 21: 251-259.
31. Szabo SJ, Kim ST, Costa GL et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000; 100: 655-669.
32. Tejani A, Suthanthiran M, Pomrantz A. A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. Nephron. 1991; 59: 96-99.
33. Tipping PG, Kitching AR. Glomerulonephritis, Th1 and Th2: what's new? Clin Exp Immunol. 2005; 142: 207-215.
34. Yap H-K, Cheung W, Murugasu B et al. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. JAmSoc Nephrol. 1999; 10: 529-537.
35. Zachwieja J, Bobkowski W, Dobrowolska-Zachwieja A et al. Intracellular cytokines of peripheral blood lymphocytes in nephrotic syndrome. Pediatr Nephrol. 2002; 17: 733-740.
36. Zhu J, Cote-Sierra J, Guo L et al. Stat5 activation plays a critical role in Th2 differentiation. Immunity. 2003; 19: 739-748.